Veness Adam M Insider Trades

Insider Trading History

Track insider trading activity for Veness Adam M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $7M 80,000 shares
Last Trade
Jun 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.46M 30,000 shares
$82.07
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $1.16M 13,229 shares
Last Trade
Jun 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.42M 30,000 shares
$80.80
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $2.63M 30,000 shares
Last Trade
Jun 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.46M 30,000 shares
$82.07
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $8.75M 100,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.25M 100,000 shares
$52.46
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $8.75M 100,000 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 100,000 shares
$22.07
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $6.56M 75,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 75,000 shares
$21.77
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Svp, General Counsel And Sec.
Holding Value $9.63M 110,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 110,000 shares
$17.88
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $0 0 shares
Last Trade
Sep 11, 2023 Sale
$61.7k 88,240 shares
$0.70
$0.70
Cyteir Therapeutics
Cyteir Therapeutics CYT
General Counsel
Holding Value $290k 96,100 shares
Last Trade
Feb 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$162k 96,100 shares
$1.69
$3.02
Cyteir Therapeutics
Cyteir Therapeutics CYT
General Counsel
Holding Value $535k 177,000 shares
Last Trade
May 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$416k 177,000 shares
$2.35
$3.02
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$4.19M 23,423 shares
$178.75
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.36M 18,806 shares
$178.75
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $0 0 shares
Last Trade
Nov 09, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$783k 4,500 shares
$173.99
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $4.19M 23,423 shares
Last Trade
Nov 09, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$783k 4,500 shares
$173.99
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $0 0 shares
Last Trade
Sep 21, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$222k 1,450 shares
$153.29
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $3.38M 18,923 shares
Last Trade
Sep 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$998k 6,650 shares
$150.05
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $4.31M 24,123 shares
Last Trade
Sep 21, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.02M 6,650 shares
$153.29
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $3.38M 18,923 shares
Last Trade
Sep 09, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$183k 1,407 shares
$130.00
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $3.63M 20,330 shares
Last Trade
Sep 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$780 6 shares
$130.00
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Svp, General Counsel And Sec.
Holding Value $3.64M 20,336 shares
Last Trade
Sep 07, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.9k 587 shares
$129.36
$178.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up